Gene · 282618
Papers3,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficient replication of influenza D virus in the human airway underscores zoonotic potential. | Proc Natl Acad Sci U S A | 2026 | 42008667 | PubTator, text mining | PubMed |
| FOXO1 transcription factor modulates airway epithelial responses to viral infection. | PLoS One | 2026 | 41931532 | PubTator, text mining | PubMed |
| Woodchuck and deer Hepatitis Delta-like agents show distinct innate immune activation and IFN-resistance compared to human Hepatitis D Virus. | Sci Rep | 2026 | 41922429 | PubTator, text mining | PubMed |
| Hepatitis E virus replication is maintained in proliferative cells within the intestinal crypt. | Sci Adv | 2026 | 41920986 | PubTator, text mining | PubMed |
| Interferon dynamics in deltaretroviruses: why HTLV-1 evades, but BLV responds. | Mol Biol Rep | 2026 | 41920397 | PubTator, text mining | PubMed |
| Monkeypox virus replication and host response in vaginal and ectocervical epithelial cells. | Virulence | 2026 | 41880196 | PubTator, text mining | PubMed |
| Bioconversion of Organosolv Lignin by Rumen Bacterium: Isolation, Characterization and Metabolic Profiling. | Molecules | 2026 | 41828891 | PubTator, text mining | PubMed |
| Differential Induction and Signaling of Type I and III Interferons During Infection of Human Nasal Epithelial Cells With the Four Human Parainfluenza Virus Types. | J Med Virol | 2026 | 41810598 | PubTator, text mining | PubMed |
| A prognostic 19-gene signature and LBP-mediated immune dysregulation define the tumor microenvironment in poor-prognosis KIRC. | Int J Med Sci | 2026 | 41799779 | PubTator, text mining | PubMed |
| MERS-CoV and SARS-CoV-1 proteins inhibit the IFN-α JAK/STAT pathway of epithelial cells, via IFN-λ-induced USP18. | Front Immunol | 2026 | 41798916 | PubTator, text mining | PubMed |
| Differential antiviral effects and immune responses in nasal and airway organoid during RSV infection: implications for interferon therapy. | Front Immunol | 2026 | 41789060 | PubTator, text mining | PubMed |
| Interplay between flaviviruses and the interferon response: mechanisms of immune evasion and therapeutic implications. | Front Pharmacol | 2026 | 41788799 | PubTator, text mining | PubMed |
| Experimental adaptation of pigeon rotavirus A (pRVA) in human colorectal cancer cells reveals interferon-driven host responses and immune checkpoint modulation. | New Microbes New Infect | 2026 | 41783245 | PubTator, text mining | PubMed |
| Transcriptomic Profile of Glioblastoma Cells Infected with Zika Virus: A Systematic Review and Pathway Analysis. | Viruses | 2026 | 41754592 | PubTator, text mining | PubMed |
| Organoids Gone Viral: A Comprehensive Review on Human Organoid Models to Study Viral Pathogenesis. | Viruses | 2026 | 41754581 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs Can Govern the Antiviral Immune Response Through Interferon-Mediated Mechanisms in Respiratory Tract. | Viruses | 2026 | 41754574 | PubTator, text mining | PubMed |
| Protease Inhibitors and Innate Immune Agonists as Antiviral Strategies Against Dengue and Zika Viruses. | Pathogens | 2026 | 41754484 | PubTator, text mining | PubMed |
| Distinct Cytokine Landscapes Induced by Influenza a Virus, RSV, and SARS-CoV-2 in Older Adults (65+) Using an Ex Vivo Whole Blood Stimulation Model. | Pathogens | 2026 | 41754392 | PubTator, text mining | PubMed |
| IL-35, IL-37, and IL-38 in acute pancreatitis: proposed immunopathogenic mechanisms and therapeutic potential. | Front Immunol | 2026 | 41737213 | PubTator, text mining | PubMed |
| The role and mechanism of IL‑35 in myasthenia gravis (Review). | Int J Mol Med | 2026 | 41716022 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/282618/papers?page=2